Raymond James Financial Services Advisors’s NanoViricides NNVC Stock Holding History

Raymond James Financial Services Advisors’s Portfolio NNVC Stock Details NNVC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-599	Closed	-$5K	–	2870
2018 Q2	$5K	Hold	599	–	–	﹤0.01%	2762
2018 Q1	$10K	Buy	599 +43	+8%	+$795	﹤0.01%	2526
2017 Q4	$10K	Hold	556	–	–	﹤0.01%	2521
2017 Q3	$13K	Hold	556	–	–	﹤0.01%	2536
2017 Q2	$15K	Hold	556	–	–	﹤0.01%	2488
2017 Q1	$12K	Hold	556	–	–	﹤0.01%	2406
2016 Q4	$12K	Buy	+556	New	+$14.8K	﹤0.01%	2325

Other funds holding NNVC

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

WBG

Wharton Business Group Malvern, Pennsylvania $2.65B AUM 20.73% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

PTB

Pioneer Trust Bank Salem, Oregon $412M AUM 17.77% 1-Year Est. Return

RJA

Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return

SCA

STALEY CAPITAL ADVISERS Pittsburgh, Pennsylvania $2.36B AUM 23.72% 1-Year Est. Return

IWM

IHT Wealth Management Chicago, Illinois $4.3B AUM 21.02% 1-Year Est. Return

Raymond James Financial Services Advisors's NNVC Position: Q3 2018 in Review

Raymond James Financial Services Advisors sold out of NanoViricides (NNVC) in Q3 2018, closing a stake of 599 shares — an estimated $5K sold.

Raymond James Financial Services Advisors first reported a position in NNVC in Q4 2016 and held it in 7 quarters. The position peaked at $15K in Q2 2017. 43 funds tracked by Wall St. Rank hold NNVC as of Q3 2018.

Raymond James Financial Services Advisors reported no remaining NanoViricides position as of Q3 2018 after selling out during the quarter.
Raymond James Financial Services Advisors sold 599 NanoViricides shares in Q3 2018, an estimated $5K.
Raymond James Financial Services Advisors first reported a position in NanoViricides in Q4 2016 and held it in 7 quarters.
Raymond James Financial Services Advisors's NanoViricides position peaked at $15K in Q2 2017.
43 funds tracked by Wall St. Rank held NanoViricides as of Q3 2018.

Based on Raymond James Financial Services Advisors's 13F filing for Q3 2018, filed 14 Nov 2018.